ALLGENESIS BIOTHERAPEUTICS INC.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
Allgenesis focuses on developing innovative ophthalmic therapies targeting both retinal and anterior segment diseases. Its pipeline includes AG-73305, a dual-action anti-VEGF and disintegrin molecule for diabetic macular edema and age-related macular dege
Founded Year
2014
Unified Business No.
54681545
Status
Active
Number of Employees
0
Total Paid-in
Capital
912,600,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Allgenesis is a privately owned, clinical stage, biopharmaceutical company situated in Taipei City, Taiwan.We strive to find solutions for major diseases of the eye affecting the vision of millions of people worldwide.Our mission is to establish a world-renowned biopharmaceutical business in Taiwan to invent and develop novel medicines for the global market.
